Answers are grounded in this paper and cite their sources.
Clinical evidence shows flunarizine may lead to depression in older patients, indicating careful management is necessary.
As a calcium channel blocker, flunarizine has a long history of successful usage in migraine prophylaxis, reducing migraine attack frequency, intensity, and duration.[1,2] Its pharmacological effects stem from its capacity to modulate neuronal excitability and decrease cortical spreading depression, two critical pathways in migraine pathophysiology.[22] There is growing evidence that flunarizine has major neuropsychiatric side effects, such as depression, which has prompted worries regarding its long-term usage, despite its proven effectiveness in migraine prevention.[3] A number of research, including randomized controlled trials, observational studies, and post-marketing monitoring studies, have shown that flunarizine does not often cause depressed symptoms in patients.[4,5] Depression is more likely to occur in older patients, those who have a history of mood disorders, and those who take higher doses of flunarizine.[6,7] Some theories propose that flunarizine-induced depression occurs as a result of drug buildup in the CNS, disruption of serotonergic and noradrenergic neurotransmission, and central dopaminergic blockage.[8,9] Since depression symptoms are frequently reversible with a decrease in dosage or withdrawal of flunarizine.[10-12] patient selection, initial psychiatric examination, and follow-up are highly important.
No takes yet. Share an insight, caveat, or question.
1G. Indira*, 2V. Abhinaya Rajeswari, 3N. Lokeswari, 4Y. Shyni, 5Dr. B. Dhanush, 6Dr. K. Padmalatha (2026) studied this question.